Literature DB >> 1329633

Effects of CO2 and pH on inhibition of TEM-1 and other beta-lactamases by penicillanic acid sulfones.

D M Livermore1, J E Corkill.   

Abstract

Incubation in 5% CO2 reduced the inhibition zones of piperacillin-tazobactam (75/10 micrograms) disks for Escherichia coli strains with TEM-1, TEM-2, and SHV-1 beta-lactamases. Similarly, MICs of piperacillin-tazobactam and other penicillin-sulfone combinations for TEM producers were up to 500-fold higher at pH 6.5 than at pH 8.0. This effect was greatest for organisms with high levels of enzyme activity. CO2 and mild acidity did not affect the susceptibility of beta-lactamase-negative strains to penicillin-sulfone combinations, and the effects of these conditions were variable for organisms with beta-lactamases other than TEM-1, TEM-2, and SHV-1. These last observations discounted acid-mediated inactivation of piperacillin or tazobactam. MICs of amoxicillin or piperacillin alone or with clavulanate for TEM and SHV producers were affected only less than or equal to 16-fold by 5% CO2 or acidity, indicating that the greater effects seen with the penicillin-sulfone combinations depended on the behavior of the sulfones and not on that of the penicillins. This pH effect was studied in detail for TEM-1 enzyme. Inhibition of this enzyme by sulfones but not clavulanate varied grossly with pH, with 50% inhibitory concentrations of tazobactam and sulbactam up to 300-fold higher at pH 6.5 than at 8.0. By contrast, the hydrolytic activity of TEM-1 enzyme for substrates and its level of production varied threefold or less between pH 6.5 and pH 8.0. Increased inhibition at pH 8.0 reflected sequestration of the enzyme into a secondary noncovalent complex rather than increased irreversible inactivation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329633      PMCID: PMC192202          DOI: 10.1128/AAC.36.9.1870

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  15 in total

Review 1.  More extended-spectrum beta-lactamases.

Authors:  G A Jacoby; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

2.  Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.

Authors:  J Kempers; D M MacLaren
Journal:  J Antimicrob Chemother       Date:  1990-10       Impact factor: 5.790

3.  Susceptibility of Escherichia coli isolates with TEM-1 beta-lactamase to combinations of BRL42715, tazobactam or clavulanate with piperacillin or amoxycillin .

Authors:  D M Livermore; P Seetulsingh
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

4.  Trimethoprim resistance conferred by W plasmids in Enterobacteriaceae.

Authors:  N Datta; R W Hedges
Journal:  J Gen Microbiol       Date:  1972-09

5.  Properties of R plasmids determining gentamicin resistance by acetylation in Pseudomonas aeruginosa.

Authors:  G A Jacoby
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

6.  Kinetic studies on the inactivation of Escherichia coli RTEM beta-lactamase by clavulanic acid.

Authors:  J Fisher; R L Charnas; J R Knowles
Journal:  Biochemistry       Date:  1978-05-30       Impact factor: 3.162

7.  Activity of clavulanate combinations against TEM-1 beta-lactamase-producing Escherichia coli isolates obtained in 1982 and 1989.

Authors:  P S Seetulsingh; L M Hall; D M Livermore
Journal:  J Antimicrob Chemother       Date:  1991-06       Impact factor: 5.790

8.  Comparative activities of the beta-lactamase inhibitors YTR 830, sodium clavulanate, and sulbactam combined with amoxicillin or ampicillin.

Authors:  S C Aronoff; M R Jacobs; S Johenning; S Yamabe
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

9.  Effect of several components of anaerobic incubation on antibiotic susceptibility test results.

Authors:  J E Rosenblatt; F Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1972-05       Impact factor: 5.191

10.  PSE-4 beta lactamase: a serotype-specific enzyme in Pseudomonas aeruginosa.

Authors:  D M Livermore; T L Pitt; C S Jones; J A Crees-Morris; R J Williams
Journal:  J Med Microbiol       Date:  1985-02       Impact factor: 2.472

View more
  10 in total

Review 1.  Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance.

Authors:  José L Martínez; Fernando Baquero
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

2.  Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

Authors:  G S Babini; M Yuan; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

Review 3.  Non-canonical mechanisms of antibiotic resistance.

Authors:  J L Martínez; J Blázquez; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-12       Impact factor: 3.267

4.  Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum beta-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa.

Authors:  S Y Essack; L M Hall; D G Pillay; M L McFadyen; D M Livermore
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

5.  Comparative in vitro activities of the novel antibacterial finafloxacin against selected Gram-positive and Gram-negative bacteria tested in Mueller-Hinton broth and synthetic urine.

Authors:  Axel Dalhoff; Will Stubbings; Sabine Schubert
Journal:  Antimicrob Agents Chemother       Date:  2011-01-18       Impact factor: 5.191

Review 6.  beta-Lactamases in laboratory and clinical resistance.

Authors:  D M Livermore
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

Review 7.  Evolution of beta-lactamase inhibitors.

Authors:  D M Livermore
Journal:  Intensive Care Med       Date:  1994-07       Impact factor: 17.440

8.  Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.

Authors:  L B Rice; L L Carias; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-03       Impact factor: 5.191

9.  Effect of pH on activities of novel beta-lactamases and beta-lactamase inhibitors against these beta-lactamases.

Authors:  S Ohsuka; Y Arakawa; T Horii; H Ito; M Ohta
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

10.  Induction of β-Lactamase Activity and Decreased β-Lactam Susceptibility by CO2 in Clinical Bacterial Isolates.

Authors:  Nathan Mullen; Hugo Raposo; Polyxeni Gudis; Linsey Barker; Romney M Humphries; Bryan H Schmitt; Ryan F Relich; Meghan May
Journal:  mSphere       Date:  2017-07-19       Impact factor: 4.389

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.